261 related articles for article (PubMed ID: 21360671)
1. Systematic quantification of peptides/proteins in urine using selected reaction monitoring.
Selevsek N; Matondo M; Sanchez Carbayo M; Aebersold R; Domon B
Proteomics; 2011 Mar; 11(6):1135-47. PubMed ID: 21360671
[TBL] [Abstract][Full Text] [Related]
2. Toward a standardized urine proteome analysis methodology.
Court M; Selevsek N; Matondo M; Allory Y; Garin J; Masselon CD; Domon B
Proteomics; 2011 Mar; 11(6):1160-71. PubMed ID: 21328537
[TBL] [Abstract][Full Text] [Related]
3. Quality control of nano-LC-MS systems using stable isotope-coded peptides.
Burkhart JM; Premsler T; Sickmann A
Proteomics; 2011 Mar; 11(6):1049-57. PubMed ID: 21328538
[TBL] [Abstract][Full Text] [Related]
4. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.
Ackermann BL; Berna MJ
Expert Rev Proteomics; 2007 Apr; 4(2):175-86. PubMed ID: 17425454
[TBL] [Abstract][Full Text] [Related]
5. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics.
Lebert D; Dupuis A; Garin J; Bruley C; Brun V
Methods Mol Biol; 2011; 753():93-115. PubMed ID: 21604118
[TBL] [Abstract][Full Text] [Related]
6. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
7. The good, the bad, the ugly: validating the mass spectrometric analysis of modified peptides.
Beck F; Lewandrowski U; Wiltfang M; Feldmann I; Geiger J; Sickmann A; Zahedi RP
Proteomics; 2011 Mar; 11(6):1099-109. PubMed ID: 21298789
[TBL] [Abstract][Full Text] [Related]
8. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
[TBL] [Abstract][Full Text] [Related]
9. Quantitative liquid chromatography tandem mass spectrometry analysis of macromolecules using signature peptides in biological fluids.
Halquist MS; Thomas Karnes H
Biomed Chromatogr; 2011 Jan; 25(1-2):47-58. PubMed ID: 21154882
[TBL] [Abstract][Full Text] [Related]
10. Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap.
Lin S; Shaler TA; Becker CH
Anal Chem; 2006 Aug; 78(16):5762-7. PubMed ID: 16906721
[TBL] [Abstract][Full Text] [Related]
11. Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.
Prakash A; Rezai T; Krastins B; Sarracino D; Athanas M; Russo P; Ross MM; Zhang H; Tian Y; Kulasingam V; Drabovich AP; Smith C; Batruch I; Liotta L; Petricoin E; Diamandis EP; Chan DW; Lopez MF
J Proteome Res; 2010 Dec; 9(12):6678-88. PubMed ID: 20945832
[TBL] [Abstract][Full Text] [Related]
12. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
13. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
15. Quality control in LC-MS/MS.
Köcher T; Pichler P; Swart R; Mechtler K
Proteomics; 2011 Mar; 11(6):1026-30. PubMed ID: 21360669
[TBL] [Abstract][Full Text] [Related]
16. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
Bronsema KJ; Bischoff R; van de Merbel NC
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
[TBL] [Abstract][Full Text] [Related]
17. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.
Dufield DR; Nemirovskiy OV; Jennings MG; Tortorella MD; Malfait AM; Mathews WR
Anal Biochem; 2010 Nov; 406(2):113-23. PubMed ID: 20603097
[TBL] [Abstract][Full Text] [Related]
18. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
[TBL] [Abstract][Full Text] [Related]
19. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
20. Generic workflow for quality assessment of quantitative label-free LC-MS analysis.
Sandin M; Krogh M; Hansson K; Levander F
Proteomics; 2011 Mar; 11(6):1114-24. PubMed ID: 21298787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
